Barchart Demo Center
Overview
Market Overview
Market Snapshot
Stocks
Stock Market Overview
Symbol Overview
Quote
Chart
Interactive Chart
News
Profile
Options
Financials
Technicals
Opinion
Earnings
Analyst Ratings
SEC Filings
Investor Relations
Stock Screeners
Most Active
Gainers
Losers
New 52-Week Highs
New 52-Week Lows
What's Hot
What's Not
ETFs
ETF Market Overview
ETF By Family
ETF Overview
ETF Quote
ETF Sectors
Futures
Futures Market Overview
Symbol Overview
Quote
Chart
Interactive Chart
News
Options
Opinion
Funds
Fund Market Overview
Fund Overview
Quote
Chart
Fund Screeners
YTD Change
New Lows
New Lows
Price Change
Percent Change
1 Month Best
3 Month Best
6 Month Best
9 Month Best
12 Month Best
1 Month Worst
3 Month Worst
6 Month Worst
9 Month Worst
12 Month Worst
What's Hot
Weekly What's Hot
Monthly What's Hot
What's Not
Weekly What's Not
Monthly What's Not
Foreign Exchange
Forex Market Overview
Symbol Overview
Chart
Sectors
Industry Market Overview
Industry Overview
Sector Overview
News
Market News
Financial Calculators
Savings Calculator
Investment Calculator
Profit Loss Calculator
RESP Calculator
RRSP Calculator
RRSP VS Non-RRSP Calculator
Embedded Widgets
Scrolling Ticker
Watchlist
The Market
Portfolio
Portfolio
Stock Alerts
News Alerts
Screener
Screener
JSON Feeds
Quotes
News
Symbol Overview
United States
|
Canada
English
|
French
Toggle navigation
Overview
Quote
Chart
News
Options
Profile
Financials
Technicals
Opinion
SEC Filings
SEC Filings
Overview
Quote
Chart
News
Options
Profile
Financials
Technicals
Opinion
SEC Filings
Lemaitre Vascular
(NASDAQ: LMAT)
Add to
Portfolio
$78.88
$78.88
+0.11
(+0.14%)
as of May 31, 2024
Report Type
All SEC Filings (excluding transactions)
Annual 10-K Reports
Quarterly 10-Q Reports
Include Stock Transaction Reports
None
All
Date
Form
Description
HTML
Word
PDF
Excel
May 31, 2024
SD
Specialized Disclosure
May 16, 2024
144
Report of proposed sale of securities
May 10, 2024
10-Q
Quarterly Report
May 06, 2024
144
Report of proposed sale of securities
May 06, 2024
144
Report of proposed sale of securities
May 06, 2024
144
Report of proposed sale of securities
May 02, 2024
8-K
Current report filing
Apr 16, 2024
ARS
Annual Report to Security Holders
Apr 16, 2024
DEF 14A
Proxy Statement (definitive)
Mar 08, 2024
144
Report of proposed sale of securities
Mar 05, 2024
144
Report of proposed sale of securities
Mar 01, 2024
144
Report of proposed sale of securities
Feb 29, 2024
144
Report of proposed sale of securities
Feb 29, 2024
144
Report of proposed sale of securities
Feb 29, 2024
144
Report of proposed sale of securities
Feb 29, 2024
10-K
Annual Report
Feb 27, 2024
8-K
Current report filing
Jan 22, 2024
SC 13G
Statement of Ownership
Dec 07, 2023
144
Report of proposed sale of securities
Nov 07, 2023
10-Q
Quarterly Report
Nov 01, 2023
8-K
Current report filing
Aug 08, 2023
10-Q
Quarterly Report
Aug 01, 2023
8-K
Current report filing
Jun 06, 2023
8-K
Current report filing
Jun 02, 2023
144
Report of proposed sale of securities
Displaying 1 - 25 of 122
←
Previous
Next
→